CAPITOL COUNSEL LLC

Lobbying for CMC PHARMACEUTICALS · Developing new and better drug formulations.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Ohio · House · Senate · $40,000.00 income · posted Apr 20, 2026

Lobbying activity 3

Budget/Appropriations

Support for Department of Defense Chemical Biological Defense medical countermeasures pre and post-exposure protection funding.

Defense

Issues related to the FY27 National Defense Authorization Act and Defense Appropriations.

Government Issues

Support for Department of Defense Chemical Biological Defense medical countermeasures pre and post-exposure protection policy.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.